Identifying giant cell arteritis patients with higher risk of relapse and vascular events: a cluster analysis

A F Guédon1, C Froger1, C Agard1

  • 1CHU Nantes, Department of Internal and Vascular Medicine, l'institut du thorax, INSERM UMR1087/CNRS UMR 6291, Team III Vascular & Pulmonary Diseases, Nantes Université, Nantes, France.

Insights

Giant cell arteritis (GCA) patient profiles vary significantly. Younger patients face vascular risks, while older individuals experience higher mortality, necessitating tailored management strategies for large vessel vasculitis.

Area of Science:

  • Rheumatology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Giant cell arteritis (GCA) is a common large vessel vasculitis (LVV).
  • High risk of relapse and cardiovascular complications in GCA patients.
  • Effective risk stratification remains a challenge in GCA management.

Purpose of the Study:

  • To perform cluster analysis in GCA patients.
  • To identify distinct patient clusters within GCA.
  • To evaluate the prognostic value of identified GCA clusters.

Main Methods:

  • Multicenter cohort study.
  • Hierarchical cluster analysis of 283 GCA patients' characteristics.
  • Assessment of relapse, cardiovascular events, and mortality incidence.

Main Results:

  • Three GCA clusters identified: 'Vascular relapsing' (23.0%), 'Typical GCA' (47.7%), and 'Ophthalmologic elderly' (29.3%).
  • 'Vascular relapsing' cluster: younger patients, frequent relapses, cardiovascular events (thoracic aortic aneurysms).
  • 'Typical GCA' cluster: classic cranial symptoms, polymyalgia rheumatica.
  • 'Ophthalmologic elderly' cluster: oldest patients, visual loss, highest mortality.

Conclusions:

  • GCA exhibits a varied prognostic landscape.
  • Younger patients with LV involvement have poor cardiovascular prognosis.
  • Elderly GCA patients face higher mortality, warranting further research on screening and intensive treatment.
Abstract